Risk of Alzheimer's disease and duration of NSAID use

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Boston Naming Test

Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378

Bayes Estimates for the Linear Model

Lindley, D. V., & Smith, A. F. M. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00885.x · Cited by 2,025

Normal Human Aging: The Baltimore Longitudinal Study on Aging

Shock, N. W., Greulich, R. C., Costa, P. T., Andres, R., Lakatta, E. G., Arenberg, D., & Tobin, J. D. (1984) · University Libraries (University of Maryland) · doi:10.13016/sclw-iccq · Cited by 757

Inverse association of anti‐inflammatory treatments and Alzheimer's disease

Breitner, J. C. S., Gau, B. A., Welsh-Bohmer, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 569

Activation of the classical complement pathway in brain tissue of Alzheimer patients

McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383

Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes.

Stremmel, W., Strohmeyer, G. W., Borchard, F., Kochwa, S., & Berk, P. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.4 · Cited by 350

A Population-Based Study of the Risk of Recurrence of Birth Defects

Lie, R. T., Wilcox, A. J., & Skjærven, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310101 · Cited by 164

Social adjustment and psychopathology among formerly hospitalized and non-hospitalized mothers—I. Development of the social role adjustment instrument

Cohler, B. J., ROBBINS, D. M., Hartman, C. R., Shader, R. I., Grunebaum, H. U., Gallant, D. H., & Weiss, J. L. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90017-5 · Cited by 132

The need for multiple time points in aging studies

Coleman, P. A., Finch, C. E., & Joseph, J. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90055-5 · Cited by 66

Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders

Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45

Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope

Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51

Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients

Seripa, D., Matera, M. G., Forno, G. D., Gravina, C., Masullo, C., Daniele, A., Binetti, G. G., Bonvicini, C., Squitti, R., Palermo, M. T., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.04.001 · Cited by 45

Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits

Maślińska, D., Laure‐Kamionowska, M., Maslinski, K. T., Gujski, M., & Maśliński, S. (2007) · Inflammation Research · doi:10.1007/s00011-006-0508-8 · Cited by 45

The combinations of TNFα-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer’s disease

Vural, P., Değirmencioğlu, S., Parıldar‐Karpuzoğlu, H., Doğru‐Abbasoğlu, S., Hanagasi, H. A., Karadağ, B., Gurvit, H. I., Emre, M., & Uysal, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01230.x · Cited by 46

Genetic basis of Alzheimer's dementia: role of mtDNA mutations

Grazina, M. M., Pratas, J., Silva, F., Oliveira, S. A., Santana, I. J., & Oliveira, C. R. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00225.x · Cited by 47

Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls

Cisbani, G., & Rivest, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01083-4 · Cited by 44

Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS

Perioli, L., Ambrogi, V., Bernardini, C., Grandolini, G., Ricci, M., Giovagnoli, S., & Rossi, C. R. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.05.006 · Cited by 45

Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation

Li, Z., Jansen, M., Pierre, S.-R., & Figueiredo‐Pereira, M. E. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00384-9 · Cited by 46

Cyclooxygenases in Central Nervous System Diseases

Graham, S. H., & Hickey, R. W. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.628 · Cited by 45

Nonsteroidal Anti‐Inflammatory Drugs, Aspirin, and Cognitive Function in the Baltimore Longitudinal Study of Aging

Waldstein, S. R., Wendell, C. R., Seliger, S. L., Ferrucci, L., Metter, E. J., & Zonderman, A. B. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02618.x · Cited by 44

Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease

Amandine, E. B., & Marchalant, Y. (2015) · Aging and Disease · doi:10.14336/ad.2015.0617 · Cited by 43

PPARgamma, neuroinflammation, and disease.

Mrak, R. E., & Landreth, G. E. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-5 · Cited by 44

Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study

Newby, D., Prieto‐Alhambra, D., Duarte‐Salles, T., Ansell, D., Pedersen, L. H., van der Lei, J., Mosseveld, M., Rijnbeek, P. R., James, G., Alexander, M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00606-5 · Cited by 45

PGH2‐derived levuglandin adducts increase the neurotoxicity of amyloid β1–42

Boutaud, O. G., Montine, T. J., Chang, L., Klein, W. L., & Oates, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03586.x · Cited by 44

Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats

Somfai, G. M., Knippel, B., Ruzicska, É., Stadler, K., Tóth, M., Salacz, G., Magyar, K., & Somogyi, A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.009 · Cited by 44

Prevention of brain aging and dementia

Ball, L. J., & Birge, S. J. (2002) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00027-7 · Cited by 42

Autotoxicity and Alzheimer Disease

McGeer, P. L., & McGeer, E. G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.789 · Cited by 44

Protective effect of irisin against Alzheimer’s disease

Chen, K., Wang, K., & Wang, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.967683 · Cited by 44

Chemical Biology, Molecular Mechanism and Clinical Perspective of γ - Secretase Modulators in Alzheimers Disease

Bulic, B., Neß, J., Hahn, S., Rennhack, A., Jumpertz, T., & Weggen, S. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376352 · Cited by 43

Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women

Kern, S., Skoog, I. G., Östling, S., Kern, J., & Börjesson‐Hanson, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001288 · Cited by 43

Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity

Barmpa, A., Hatzidimitriou, A. G., & Psomas, G. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111357 · Cited by 43

Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice

Subaiea, G. M., Adwan, L. I., Ahmed, A. H., Stevens, K. E., & Zawia, N. H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.002 · Cited by 45

PROVIDING DENTAL CARE FOR PATIENTS DIAGNOSED WITH ALZHEIMER’S DISEASE

Henry, R. G., & Wekstein, D. R. (1997) · Dental Clinics of North America · doi:10.1016/s0011-8532(22)00051-9 · Cited by 44

Effects of intermittent fasting on age-related changes on Na,K-ATPase activity and oxidative status induced by lipopolysaccharide in rat hippocampus

Vasconcelos, A. R., Kinoshita, P. F., Yshii, L., Orellana, A. M., Böhmer, A. E., Lima, L. D. S., Alves, R., Andreotti, D. Z., Marcourakis, T., Scavone, C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.020 · Cited by 42

Impact of the Type and Severity of Dementia on Hospitalization and Survival of the Elderly

Landi, F., Gambassi, G., Lapane, K. L., Sgadari, A., Mor, V., & Bernabei, R. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017112 · Cited by 42

Glucocorticoids in Alzheimer??s Disease

Aisen, P. S. S., & Pasinetti, G. M. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00001 · Cited by 42

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease

Fagan, S. G., Béchet, S., & Dev, K. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02613-5 · Cited by 41

Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions

Klaver, D. W., Wilce, M. C. J., Cui, H., Hung, A. C., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Biological Chemistry · doi:10.1515/bc.2010.089 · Cited by 41

Estrogen and the Treatment of Alzheimer’s Disease

Birge, S. J., & Mortel, K. F. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00258-1 · Cited by 40

The Mechanism of Action of Anti-Inflammatory Drugs

Vane, J. R. (2000) · Springer eBooks · doi:10.1007/978-3-662-04047-8_1 · Cited by 40

Prevention of Alzheimer's disease

Szekely, C. A., Breitner, J. C. S., & Zandi, P. P. (2007) · International Review of Psychiatry · doi:10.1080/09540260701797944 · Cited by 41

Isolevuglandin Adducts in Disease

Salomon, R. G., & Bi, W.-Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6154 · Cited by 40

Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases

Upadhyay, A., Amanullah, A., Joshi, V., Dhiman, R., Prajapati, V. K., Poluri, K. M., & Mishra, A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1903488 · Cited by 40

Adenosine receptor signalling in Alzheimer’s disease

Trinh, P. N. H., Baltos, J., Hellyer, S. D., May, L. T., & Gregory, K. J. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09883-1 · Cited by 43

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

Kosloski, L. M., Ha, D. M., Hutter-Saunders, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40

Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases

Mannila, A., Rautio, J., Lehtonen, M., Järvinen, T., & Savolainen, J. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.004 · Cited by 40

Alzheimer's Disease

Holroyd, S., & Shepherd, M. L. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00193-x · Cited by 39

In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation

Lee, H., Villacreses, N., Rapoport, S., & Rosenberger, T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02786.x · Cited by 41

Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases

Choudhury, A., Sahu, T., Ramanujam, P. L., Banerjee, A. K., Chakraborty, I., Arun Kumar, R., & Arora, N. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000361 · Cited by 41

Treatment of Alzheimer’s Disease: Current Approaches and Promising Developments

Small, G. W. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00027-8 · Cited by 41

Thrombin, a Key Driver of Pathological Inflammation in the Brain

Iannucci, J., & Grammas, P. (2023) · Cells · doi:10.3390/cells12091222 · Cited by 40

Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide

Rocha, N. P., Teixeira, A. L., Coelho, F. M., Caramelli, P., Guimarães, H. C., Barbosa, I. G., Silva, T. A., Mukhamedyarov, M. A., Zefirov, A. L., Rizvanov, A. A., et al. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.09.005 · Cited by 39

Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity

Coppola, J. M., Hamilton, C. A., Bhojani, M. S., Larsen, M. J., Ross, B. D., & Rehemtulla, A. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.01.013 · Cited by 38

Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect

Bour, A. M. J. J., Westendorp, R. G. J., Laterveer, J. C., Bollen, E. L. E. M., & Remarque, E. J. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00128-5 · Cited by 38

Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion

Wilhelmus, M. M. M., Boelens, W. C., Kox, M., Maat–Schieman, M. L. C., Veerhuis, R., de Waal, R. M. W., & Verbeek, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.001 · Cited by 38

R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.

Klegeris, A., & McGeer, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7517 · Cited by 44

Can peripheral leukocytes be used as Alzheimer’s disease biomarkers?

Rezai-Zadeh, K. P., Gate, D., Szekely, C. A., & Town, T. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.118 · Cited by 36

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 37

Microglial EP2 as a New Target to Increase Amyloid β Phagocytosis and Decrease Amyloid β-Induced Damage to Neurons

Shie, F., Montine, K. S., BREYER, R. M., & Montine, T. J. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00509.x · Cited by 37

Dementia / Alzheimer's Disease

Lindsay, J., & Anderson, L. (2004) · BMC Women s Health · doi:10.1186/1472-6874-4-s1-s20 · Cited by 41

Treatments for Alzheimer Disease

Potyk, D. K. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000166671.86815.c1 · Cited by 37

Expression of invariant chain and pro-cathepsin L in Alzheimer's brain

Yoshiyama, Y., Arai, K., Oki, T., & Hattori, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01326-4 · Cited by 37

Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial

Aisen, P. S. S. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00312.x · Cited by 36

Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology

Beeri, M. S., Schmeidler, J., Lesser, G. T., Maroukian, M., West, R. K., Leung, S., Wysocki, M., Perl, D. P., Purohit, D. P., & Haroutunian, V. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.011 · Cited by 36

Ligand modulation of glial activation: cell permeable, small molecule inhibitors of serine-threonine protein kinases can block induction of interleukin 1β and nitric oxide synthase II

Watterson, D., Mirzoeva, S., Guo, L.-Y., Whyte, A., Bourguignon, J., Hibert, M., Haiech, J., & Eldik, L. V. V. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00053-5 · Cited by 33

Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease

Saeedi, M., & Mehranfar, F. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220302115901 · Cited by 36

Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 36

Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates

Schiefer, I. T., Abdul‐Hay, S. O., Wang, H., Vanni, M., Qin, Z., & Thatcher, G. R. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101450p · Cited by 34

Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype

Cervilla, J. A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.028076 · Cited by 34

Pathophysiological Effects of Dietary Essential Fatty Acid Balance on Neural Systems

Yoshida, S., Sato, A., & Okuyama, H. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.77.11 · Cited by 34

Immunology meets neuroscience – Opportunities for immune intervention in neurodegenerative diseases

Lynch, M. A., & Mills, K. H. G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.013 · Cited by 34

A Population Study of Alzheimer's Disease: Findings From the Cache County Study on Memory, Health, and Aging

Tschanz, J. T., Treiber, K., Norton, M. C., Welsh-Bohmer, K. A., Toone, L., Zandi, P. P., Szekely, C. A., Lyketsos, C. G., Breitner, J. C. S., & The Cache County Study Group (2005) · Care management journals · doi:10.1891/cmaj.6.2.107 · Cited by 32

Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer’s disease

Babiloni, C., Frisoni, G. B., Percio, C. D., Zanetti, O. O., Bonomini, C., Cassetta, E., Pasqualetti, P., Miniussi, C., Rosas, M. D., Valenzano, A. A., et al. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.02.005 · Cited by 33

A novel pleiotropic effect of aspirin: Beneficial regulation of pro- and anti-inflammatory mechanisms in microglial cells

Kata, D., Földesi, I., Fehér, L. Z., Hackler, L., Puskás, L. G., & Gulya, K. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.009 · Cited by 34

Decreased physical function in juvenile rheumatoid arthritis

Miller, M. L., Kress, A. M., & Berry, C. A. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)12:5 · Cited by 27

Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol

Landolfi, C., Soldo, L., Polenzani, L., Apicella, C., de Joannon, A. C., Coletta, I., Cesare, F. D., Brufani, M., Pinza, M., & Milanese, C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00663-3 · Cited by 33

Nonsteroidal Anti-Inflammatory Drugs and Cognitive Function

Karplus, T. M., & Saag, K. G. (1998) · Drug Safety · doi:10.2165/00002018-199819060-00001 · Cited by 33

Salicylate, an aspirin metabolite, specifically inhibits the current mediated by glycine receptors containing α1‐subunits

Lu, Y., Tang, Z., Ye, Z., Wang, H., Huang, Y., Zhou, K., Zhang, M., Xu, T. L., & Chen, L. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00321.x · Cited by 32

Frontiers in Alzheimer’s disease therapeutics

Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 32

miRNA 933 Expression by Endothelial Cells is Increased by 27-Hydroxycholesterol and is More Prevalent in Plasma from Dementia Patients

Dias, I. H. K., Brown, C. L., Shabir, K., Polidori, M. C., & Griffiths, H. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180201 · Cited by 32

Traumatic Brain Injury and Suicidal Behavior: A Review

Wadhawan, A., Stiller, J. W., Potocki, E., Okusaga, O. O., Dagdag, A., Lowry, C. A., Benros, M. E., & Postolache, T. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181055 · Cited by 40

Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms

Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 33

The Burden of Dementia: A Medical and Research Perspective

Antuono, P., & Beyer, J. (1999) · Metamedicine · doi:10.1023/a:1009915605467 · Cited by 32

TAM receptor deficiency affects adult hippocampal neurogenesis

Ji, R., Meng, L., Li, Q., & Lu, Q. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9636-y · Cited by 36

Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease

Scorer, C. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02042-6 · Cited by 32

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review

Thong, E. H., Quek, J. W. E., Loo, J. H., Yun, C.-Y., Teo, Y. N., Teo, Y. H., Leow, A. S., Li, T. Y., Sharma, V. K., Tan, B. Y., et al. (2023) · Biology · doi:10.3390/biology12081154 · Cited by 31

Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice

Zhang, Z., Tan, X., Sun, X., Wei, J., Li, Q. X., & Wu, Z. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab328 · Cited by 32

What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?

Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 32

INFLAMMATION AND ALZHEIMER'S DISEASE

Gupta, A., & Pansari, K. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11394.x · Cited by 31

Genes involved in Alzheimer's disease, a survey of possible candidates

Serretti, A., Artioli, P., Quartesan, R., & Ronchi, D. D. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7410 · Cited by 32

Pharmacologic Management of Alzheimer Disease Part III: Nonsteroidal Antiinflammatory Drugs — Emerging Protective Evidence?

Flynn, B. L., & Theesen, K. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17093 · Cited by 31

Neuroinflammation and β Amyloid Deposition in Alzheimer's Disease: In vivo Quantification with Molecular Imaging

Hommet, C., Mondon, K., Camus, V., Ribeiro, M. J., Beaufils, É., Arlicot, N., Corcia, P., Paccalin, M., Minier, F., Gosselin, T., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000354363 · Cited by 36

Genetic analysis of tumor necrosis factor-α (TNF-α) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease

Wang, B., Zhou, S., Yang, Z., Xie, Y., Wang, J., Zhang, P., Lv, Z., Zheng, C., & Ma, X. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.021 · Cited by 30

Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation

Kasatkina, L. A., Heinemann, Á., Hudz, Y. A., Thomas, D., & Sturm, E. M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113783 · Cited by 30

Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer’s Disease: Potential and Challenges

Jain, S., Singh, R., Paliwal, S., & Sharma, S. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230511122435 · Cited by 35

The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines

Stone, T. W., Behan, W. M. H., Jones, P. A., Darlington, L. G., & Smith, R. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3401 · Cited by 30

Microsomal prostaglandin E synthase-2: Cellular distribution and expression in Alzheimer's disease

Chaudhry, U. A., Zhuang, H., & Doré, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.027 · Cited by 30

Identification of a Novel Dehydroergosterol Enhancing Microglial Anti-Inflammatory Activity in a Dairy Product Fermented with Penicillium candidum

Ano, Y., Kutsukake, T., Hoshi, A., Yoshida, A., & Nakayama, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116598 · Cited by 29

Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2

Spielman, L. A., Winger, D. I., Ho, L., Aisen, P. S. S., Shohami, E., & Pasinetti, G. M. (2002) · Acta Neuropathologica · doi:10.1007/s004010100447 · Cited by 30

Curcumin Requires Tumor Necrosis Factor α Signaling to Alleviate Cognitive Impairment Elicited by Lipopolysaccharide

Kawamoto, E. M., Scavone, C., Mattson, M. P., & Camandola, S. (2012) · Neurosignals · doi:10.1159/000336074 · Cited by 30

Epidemiologie der Demenzen

Bickel, H. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_2 · Cited by 30

Low-dose aspirin for in vitro fertilisation

Poustie, V., Dodd, S. R., & Drakeley, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004832.pub2 · Cited by 30

Aspirin for in vitro fertilisation

Siristatidis, C. S., Dodd, S. R., & Drakeley, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004832.pub3 · Cited by 30

Prolong Exposure of NSAID in Patients With RA Will Decrease the Risk of Dementia

Chang, K., Hsu, Y., Hsu, C.-C., Lin, C., Hsu, C. Y., Lee, C., Chong, L.-W., Liu, H.-C., Lin, M., & Kao, C. (2016) · Medicine · doi:10.1097/md.0000000000003056 · Cited by 29

Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs

Ferencĭk, M., Novák, M., Rovensky, J., & Rybár, I. (2001) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656411 · Cited by 29

The pharmacogenomics of Alzheimer's disease

Crentsil, V. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2003.07.003 · Cited by 29

Cyclooxygenase-Dependent Lipid-Modification of Brain Proteins

Boutaud, O. G., Andreasson, K. I., Zagol-Ikapitte, I. A., & Oates, J. A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00510.x · Cited by 29

Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies

Lyketsos, C. G., Szekely, C. A., Mielke, M. M., Rosenberg, P. B., & Zandi, P. P. (2008) · International Psychogeriatrics · doi:10.1017/s1041610208007382 · Cited by 28

Presenilin/γ-secretase and inflammation

Saura, C. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00016 · Cited by 30

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?

Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B., & Albert Hofman, D. (1995) · Neurology · doi:10.1212/wnl.45.8.1441 · Cited by 284

Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients

Landi, F., Cesari, M., Onder, G., Russo, A., Torre, S., & Bernabei, R. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00008 · Cited by 51

NSAIDs and incident Alzheimer’s disease. The Rotterdam study

In ’t Veld, B. A., Launer, L. J., Hoes, A. W., Ott, A., Hofman, A., Breteler, M. M. B., & Stricker, B. H. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00096-7 · Cited by 145

Anti-Inflammatory Drugs and Risk of Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis

Wang, J., Tan, L., Wang, H.-F., Tan, C.-C., Meng, X.-F., Wang, C., Tang, S.-W., & Yu, J.-T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141506 · Cited by 234